[1] NGUYEN Q T, CHOI J, YANG J K,et al.Ufd1 phosphorylation at serine 229 negatively regulates endoplasmic reticulum-associated degradation by inhibiting the interaction of Ufd1 with VCP[J].Biochem J,2019,476(18):2561-2577. [2] MOHAMMED S I, REN W, FLOWERS L, et al. Point-of-care test for cervical cancer in LMICs[J]. Oncotarget, 2016, 7(14):18787-18797. [3] TSUJIMOTO Y, TOMITA Y, HOSHIDA Y,et al. Elevated Expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer[J]. Clin Cancer Res, 2004, 10(9):3007-3012. [4] LONG X H, ZHANG Z H, LIU Z L, et al. Inhibiting valosin-containing protein suppresses osteosarcoma cell metastasis via AKT/nuclear factor of kappa B signaling pathway in vitro[J]. Indian J of Pathol Microbiol, 2013, 56(3):190-195. [5] BRANDMAN O, HEGDE R S.Ribosome-associated protein quality control[J]. Nat Struct Mol Biol, 2016, 23(1):7-15. [6] ANDERSON D J, LEMOIGNE R, DIAKOVIC S, et al. Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis[J].Cancer Cell, 2015, 28(5):653-665. [7] ZHOU H J,WANG J H,YAO B, et al.Discovery of a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase (CB-5083)[J].J Med Chem,2015, 58(24):9480-9497. [8] ASAI T, TOMITA Y, NAKATSUKA S,et al.VCP (p97) regulates NFκB signaling pathway, which is important for metastasis of osteosarcoma cell line[J]. Jpn J Cancer Res, 2002, 93(3):296-304. [9] YU L, YAN H, QING M S, et al. VCP/P97, down-regulated by microRNA- 129-5p, could regulate the progression of hepatocellular carcinoma[J]. PLoS One, 2012, 7(4):35800-35808. [10] QIU Y, MORII E, TOMITA Y, et al. Prognostic significance of pre B cell leukemia transcription factor 2(PBX2) expression in non-small cell lung carcinoma[J]. Cancer Sci, 2009, 100(7):1198-1209. [11] VALLE C W, MIN T, BODAS M, et al. Critical role of VCP/P97 in the pathogenesis and progression of non-small cell lung carcinoma[J]. PLoS One, 2011, 6(12):e29073. [12] ZHU W W, KANG L, GAO Y P, et al. Expression level of valosin containing protein is associated with prognosis of primary orbital MALT lymphoma[J]. Asian Pac J Cancer Prev, 2013, 14(11):6439-6443. [13] MEYER M F, SEUTHE I M C, DREBBER U, et al. Valosin-containing protein (VCP/P97)expression correlates with prognosis of HPV-negative oropharyngeal squamous cell carcinoma (OSCC)[J]. PLoS One, 2014, 9(12):e114170. [14] LUO H, SONG H, MAO R, et al. Targeting valosin containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma[J]. Cancer Sci, 2019,110(11):3464-3475. [15] ZHU W, LI D, XIAO L.Upregulation of valosin-containing protein (VCP) is associated with poor prognosis and promotes tumor progression of orbital B-cell lymphoma[J].Onco Targets Ther,2019,12:243-253. [16] LI W, TAN D F, ZENELI M J, et al. Constitutive activation of nuclear factor-kappa B (NF-κB) signaling pathway in fibrolamellar hepatocellular carcinoma[J]. Int J Clin Exp Pathol, 2010, 3(3):238-243。 [17] XIA L,XUE X Z. Immunohistochemical study of NF-κB/P65, c-IAP2 and caspase-3 expression in cervical cancer[J]. Oncol Lett, 2012, 3(4):839-844. [18] MENG L L, WANG J L, XU S P, et al. Low serum gastrin associated with ER+ breast cancer development via inactivation of CCKBR/ERK/P65 signaling[J]. BMC Cancer, 2018, 18(1):824-837. [19] KATRIN S, ALEXANDER P, MICHAEL N. p97/VCP promotes Cullin- RING- ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα[J]. J Cell Mol Med, 2016,20(1):58-70. [20] 刘钧, 李天虚, 焦伯延. VCP通过促进Huh7肝癌细胞P-IκB的降解激活NF-κB[J]. 中国卫生检验杂志, 2015,25(6):863-865. |